What is Briya?
Founded in 2021, Briya operates at the intersection of distributed ledger technology and healthcare informatics. The platform addresses the persistent challenge of data silos within the medical industry, providing a robust framework that allows hospitals and research institutions to monetize and share insights without compromising patient confidentiality. By leveraging blockchain, Briya ensures an immutable audit trail for every data transaction, which is essential for regulatory compliance in highly sensitive environments. The company's market position is defined by its ability to transform static, fragmented records into dynamic, actionable intelligence, thereby creating new revenue streams for healthcare providers while accelerating clinical research and development cycles.
How much funding has Briya raised?
Briya has raised a total of $17M across 2 funding rounds:
Angel/Seed
$5.5M
Series A
$11.5M
Angel/Seed (2022): $5.5M with participation from Amiti Ventures, Innocare Health Investments, and Insight Partners
Series A (2023): $11.5M led by Insight Partners, Amity Ventures, and Team8
Key Investors in Briya
Insight Partners
A global software-focused venture capital and private equity firm that provides capital and operational support to high-growth technology companies through its dedicated portfolio leadership platform.
Amity Ventures
A venture firm focused on supporting founders in building category-defining businesses, with a portfolio that spans enterprise SaaS, mobile databases, and cloud-based communication solutions.
Team8
A company-building venture group specializing in enterprise technology, AI, and cybersecurity, founded by serial entrepreneurs and former leaders of elite intelligence units.
What's next for Briya?
With this major enterprise-level funding, Briya is poised to scale its operations and expand its footprint within the global healthcare ecosystem. The strategic roadmap likely involves deepening its integration capabilities with existing electronic health record systems and enhancing its analytical tools to provide more granular insights for pharmaceutical and research partners. As the demand for interoperable, secure data grows, Briya's focus will remain on scaling its infrastructure to support larger enterprise clients, ensuring that its blockchain-based exchange remains the gold standard for privacy-first data collaboration. The company is well-positioned to capitalize on the increasing shift toward data-driven medicine, leveraging its recent capital infusion to solidify its competitive advantage in the healthtech landscape.
See full Briya company page
